Leonard_2017_J.Pharmacol.Exp.Ther_363_314

Reference

Title : Cannabinoid CB(1) Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors - Leonard_2017_J.Pharmacol.Exp.Ther_363_314
Author(s) : Leonard MZ , Alapafuja SO , Ji L , Shukla VG , Liu Y , Nikas SP , Makriyannis A , Bergman J , Kangas BD
Ref : Journal of Pharmacology & Experimental Therapeutics , 363 :314 , 2017
Abstract : Leonard_2017_J.Pharmacol.Exp.Ther_363_314
ESTHER : Leonard_2017_J.Pharmacol.Exp.Ther_363_314
PubMedSearch : Leonard_2017_J.Pharmacol.Exp.Ther_363_314
PubMedID: 28947487

Related information

Citations formats

Leonard MZ, Alapafuja SO, Ji L, Shukla VG, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD (2017)
Cannabinoid CB(1) Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors
Journal of Pharmacology & Experimental Therapeutics 363 :314

Leonard MZ, Alapafuja SO, Ji L, Shukla VG, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD (2017)
Journal of Pharmacology & Experimental Therapeutics 363 :314